Fesik SW - Search Results

1

Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J, Swift K, Matayoshi ED, Zhang H, Thompson CB, Fesik SW. Petros AM, et al. Among authors: fesik sw. Protein Sci. 2000 Dec;9(12):2528-34. doi: 10.1110/ps.9.12.2528. Protein Sci. 2000. PMID: 11206074 Free PMC article.

2

Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus.

Huang Q, Petros AM, Virgin HW, Fesik SW, Olejniczak ET. Huang Q, et al. Among authors: fesik sw. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3428-33. doi: 10.1073/pnas.062525799. Proc Natl Acad Sci U S A. 2002. PMID: 11904405 Free PMC article.

3

Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2.

Huang Q, Petros AM, Virgin HW, Fesik SW, Olejniczak ET. Huang Q, et al. Among authors: fesik sw. J Mol Biol. 2003 Oct 3;332(5):1123-30. doi: 10.1016/j.jmb.2003.08.007. J Mol Biol. 2003. PMID: 14499614

4

Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.

Petros AM, Gunasekera A, Xu N, Olejniczak ET, Fesik SW. Petros AM, et al. Among authors: fesik sw. FEBS Lett. 2004 Feb 13;559(1-3):171-4. doi: 10.1016/S0014-5793(04)00059-6. FEBS Lett. 2004. PMID: 14960327 Free article.

5

Structural biology of the Bcl-2 family of proteins.

Petros AM, Olejniczak ET, Fesik SW. Petros AM, et al. Among authors: fesik sw. Biochim Biophys Acta. 2004 Mar 1;1644(2-3):83-94. doi: 10.1016/j.bbamcr.2003.08.012. Biochim Biophys Acta. 2004. PMID: 14996493 Free article. Review.

6

Over-expression of the human MDM2 p53 binding domain by fusion to a p53 transactivation peptide.

Liu Z, Olejniczak ET, Fesik SW. Liu Z, et al. Among authors: fesik sw. Protein Expr Purif. 2004 Oct;37(2):493-8. doi: 10.1016/j.pep.2004.06.036. Protein Expr Purif. 2004. PMID: 15358376

7

Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis.

Petros AM, Dinges J, Augeri DJ, Baumeister SA, Betebenner DA, Bures MG, Elmore SW, Hajduk PJ, Joseph MK, Landis SK, Nettesheim DG, Rosenberg SH, Shen W, Thomas S, Wang X, Zanze I, Zhang H, Fesik SW. Petros AM, et al. Among authors: fesik sw. J Med Chem. 2006 Jan 26;49(2):656-63. doi: 10.1021/jm0507532. J Med Chem. 2006. PMID: 16420051

8

Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR.

Meadows RP, Nettesheim DG, Xu RX, Olejniczak ET, Petros AM, Holzman TF, Severin J, Gubbins E, Smith H, Fesik SW. Meadows RP, et al. Among authors: fesik sw. Biochemistry. 1993 Jan 26;32(3):754-65. doi: 10.1021/bi00054a004. Biochemistry. 1993. PMID: 7678499

9

Solution structure of the ets domain of Fli-1 when bound to DNA.

Liang H, Mao X, Olejniczak ET, Nettesheim DG, Yu L, Meadows RP, Thompson CB, Fesik SW. Liang H, et al. Among authors: fesik sw. Nat Struct Biol. 1994 Dec;1(12):871-5. doi: 10.1038/nsb1294-871. Nat Struct Biol. 1994. PMID: 7773776

10

The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein.

Liang H, Olejniczak ET, Mao X, Nettesheim DG, Yu L, Thompson CB, Fesik SW. Liang H, et al. Among authors: fesik sw. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11655-9. doi: 10.1073/pnas.91.24.11655. Proc Natl Acad Sci U S A. 1994. PMID: 7972119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page